One more observation from what Dr Patterson said a
Post# of 148190
.Keytruda and Optiva he gave as an example .
At 200,000.00 a year per person they stop working about 3-6 months later , because many new cells which controlling tumors coming with their CCR5 .
Leronlimab might control that !!!!!
I remember Dr NP said long time ago that they thinking of doing study with Keytruda .., now with Dr Patterson observation hopefully it will be done soon .
First Letonlimab most probably could control all those often very severe autoimmune side effects of check point inhibitors , and now we know that it could control developing of resistance to them ...
Anytime we listen to any talks about Leronlimab we learning some new very exciting things !!!!